Elgethun Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$13.6K	Hold	15,000	–	–	﹤0.01%	150
2025 Q1	$6.77K	Hold	15,000	–	–	﹤0.01%	151
2024 Q4	$7.54K	Hold	15,000	–	–	﹤0.01%	154
2024 Q3	$13.6K	Hold	15,000	–	–	﹤0.01%	153
2024 Q2	$15K	Hold	15,000	–	–	﹤0.01%	153
2024 Q1	$21.5K	Hold	15,000	–	–	0.01%	153
2023 Q4	$16.4K	Hold	15,000	–	–	﹤0.01%	152
2023 Q3	$18K	Hold	15,000	–	–	0.01%	152
2023 Q2	$21.2K	Hold	15,000	–	–	0.01%	153
2023 Q1	$22.7K	Hold	15,000	–	–	0.01%	126
2022 Q4	$18.8K	Hold	15,000	–	–	0.01%	121
2022 Q3	$17K	Hold	15,000	–	–	0.01%	117
2022 Q2	$24K	Hold	15,000	–	–	0.01%	115
2022 Q1	$23K	Hold	15,000	–	–	0.01%	111
2021 Q4	$38K	Hold	15,000	–	–	0.01%	107
2021 Q3	$38K	Hold	15,000	–	–	0.01%	105
2021 Q2	$43K	Hold	15,000	–	–	0.01%	102
2021 Q1	$35K	Hold	15,000	–	–	0.01%	100
2020 Q4	$26K	Hold	15,000	–	–	0.01%	98
2020 Q3	$14K	Hold	15,000	–	–	0.01%	93
2020 Q2	$13K	Hold	15,000	–	–	0.01%	96
2020 Q1	$12K	Hold	15,000	–	–	0.01%	96
2019 Q4	$13K	Buy	+15,000	New	+$13K	0.01%	93
2019 Q3	–	Sell	-15,000	Closed	-$17K	–	96
2019 Q2	$17K	Hold	15,000	–	–	0.01%	91
2019 Q1	$20K	Hold	15,000	–	–	0.01%	90
2018 Q4	$16K	Sell	15,000 -2,145	-13%	-$2.29K	0.01%	88
2018 Q3	$35K	Hold	17,145	–	–	0.02%	82
2018 Q2	$31K	Hold	17,145	–	–	0.02%	85
2018 Q1	$40K	Hold	17,145	–	–	0.03%	93
2017 Q4	$32K	Hold	17,145	–	–	0.02%	89
2017 Q3	$43K	Hold	17,145	–	–	0.03%	85
2017 Q2	$47K	Hold	17,145	–	–	0.04%	82
2017 Q1	$52K	Hold	17,145	–	–	0.04%	76
2016 Q4	$54K	Buy	+17,145	New	+$54K	0.04%	128